arrow
A

Aditi Bhatt

Shalby Hospitals
H指数:22
被引数:1,754

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Structured operative reporting for cytoreductive surgery: the CRS-Report platform

细胞减灭术的结构化操作报告:CRS-Report平台

EJSO
IF2.9
2026-10-130
PRE
Comparative oncological efficacy of chemotherapy, cytoreductive surgery with or without HIPEC in recurrent ovarian cancer: A network meta-analysis

化疗、减瘤术(含或不含HIPEC)治疗复发性卵巢癌的肿瘤学疗效比较:一项网络Meta分析

EJSO
IF2.9
2026-09-110
PRE
Ca125 KELIM as a Potential Tool for Predicting Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Benefit at Interval Cytoreductive Surgery for Advanced Epithelial Ovarian Cancer-A Propensity Score-Matched Analysis

CA125 KELIM作为预测间隔肿瘤细胞减灭术治疗晚期上皮性卵巢癌患者腹腔热灌注化疗(HIPEC)获益的潜在工具——一项倾向性评分匹配分析

2026-07-010
PRE
ASO Visual Abstract: MORPHology and Inter-Observer Variation in Peritoneal Disease Assessment Among Expert Peritoneal Malignancy SUrgeonS—The MORPHEUS Study

ASO视觉摘要:MORPHology和观察者间差异在腹膜疾病评估中的研究——专家腹膜恶性肿瘤外科医生研究(MORPHEUS研究)

2026-04-010
PRE
Principles of cytoreductive surgery for primary and metastatic peritoneal malignancies—the PSOGI–ESGO–ISSPP Lyon consensus

原发性及转移性腹膜恶性肿瘤细胞减灭术的原则——PSOGI–ESGO–ISSPP里昂共识

2026-03-300
PRE
MORPHology and Inter-observer Variation in Peritoneal Disease Assessment Among Expert Peritoneal Malignancy SUrgeonS: The MORPHEUS study

形态学及观察者间变异在腹膜疾病评估中的研究:专家腹膜恶性肿瘤外科医师的MORPHEUS研究

2026-03-100
PRE
Development of a history-taking form for mesothelioma patients at risk of exposure to asbestos

为有石棉暴露风险的间皮瘤患者开发一份病史采集表

2025-12-030
PRE
Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensus

PSOGI-ESGO-ISSPP合作者。腹膜切除术治疗腹膜表面恶性肿瘤:PSOGI-ESGO-ISSPP里昂共识

2025-01-010
PRE
Peritonectomy to enhance adequate cytoreductive surgery in peritoneal surface malignancy: review of nomenclature and boundaries

腹膜切除术以增强腹膜表面恶性肿瘤的充分细胞减灭术:命名法和边界的综述

2025-01-010
PRE